The combination of genomic microarrays with comparative genomic hybridization and with chromatin immunoprecipitation is providing an increasingly detailed view of the way in which the human genome is organized and functions and how disorganization and disfunction can lead to disease. These studies are enhanced by the flexibility of array technology, allowing resolutions from coverage of the whole genome using 200 kb cloned DNA inserts to detailed analysis using PCR products or oligonucleotides of 100 bp or less. In particular, the use of chromatin immunoprecipitation is providing new insights into chromosome structure and gene regulation and control through the analysis of protein -DNA interactions.
The combination of genomic microarrays with comparative genomic hybridization and with chromatin immunoprecipitation is providing an increasingly detailed view of the way in which the human genome is organized and functions and how disorganization and disfunction can lead to disease. These studies are enhanced by the flexibility of array technology, allowing resolutions from coverage of the whole genome using 200 kb cloned DNA inserts to detailed analysis using PCR products or oligonucleotides of 100 bp or less. In particular, the use of chromatin immunoprecipitation is providing new insights into chromosome structure and gene regulation and control through the analysis of protein -DNA interactions.
The DNA (2 m) which comprises the human cell nucleus is condensed and packaged by being wrapped around histone octamers in nucleosomes which themselves are organized into higher ordered structures. This is most clearly visualized as the highly condensed chromosomes visible at metaphase prior to cell division. During interphase, the chromatin remains organized into chromosomal domains where expressed regions become decondensed to facilitate transcription and silenced regions remain in a condensed form (1) . This hints at the functional role of chromatin, which in recent years, we have come to realize is important in the regulation of gene expression in development and its maintenance in differentiation (2 -4) . Thus, chromosome structure and function are not simply determined by the linear sequence and the genes and regulatory elements for which it codes, but also by higher order chromatin organization. Disruptions in this organization often lead to disease.
With the publication of the finished sequence of the human genome we now have access not only to the linear sequence of DNA base pairs, but also to a bewildering diversity of mapped cloned DNA resources. These resources have been harnessed in the form of genomic DNA microarrays to allow widescale or detailed analysis of chromosome structure and function. Typically, the microarray comprises a substrate onto which a large number of genomic DNA sequences are individually synthesized or spotted. Current technology allows over 60 000 features (spots) on a standard microscope slide. The features are then utilized as probes allowing highly parallel analysis of the abundance of homologous sequences in the DNA sample hybridized to the array. This current restriction in the number of features limits the scope and resolution of the arrays. Probes are typically derived from cloned genomic DNA inserts, PCR amplicons or oligonucleotides designed directly from the sequence. While the whole genome can be covered with 30 000 large insert clones of over 100 kb in size (5), for higher resolution analysis of DNA -protein interaction or chromatin modifications, over three million sequences of 1 kb in size would be required. As this is not currently achievable, higher resolution arrays are generally restricted to smaller areas of the genome or to specific chromosomes (6, 7) .
DNA MICROARRAYS AND COMPARATIVE GENOMIC HYBRIDIZATION
In a typical experiment using a spotted clone array, a test DNA and a reference DNA are labelled with different fluorochromes and co-hybridized (usually in the presence of unlabelled DNA to block shared repeat sequences) to the array (Fig. 1) . After hybridization and washing, the microarray is scanned and the fluorescence intensity of each fluorochrome for each feature quantified. In this way, for each feature, the relative fluorescence intensity of the test to reference sample is determined and differences between the abundance of complementary sequences in the two hybridized DNAs quantified. This process is analogous to comparative genomic hybridization (CGH) where differentially labelled test and Human Molecular Genetics, Vol. 13, Review Issue 2 # Oxford University Press 2004; all rights reserved *To whom correspondence should be addressed. Tel: þ44 1223494860; Fax: þ44 1223494919; Email: npc@sanger.ac.uk reference genomes are hybridized to metaphase spreads and the relative genomic copy number determined along each chromosome, thus indentifying aberration in chromosome structure (8) . In CGH, the detection of gains and losses in the genome are limited to a resolution of 5 Mb by the highly condensed target DNA in the metaphase chromosomes (9) . Microarrays are now replacing metaphase spreads as the target for hybridization in these studies (10, 11) so that in array-CGH, resolution is now limited only by the size and density of the target sequences. Typically, studies utilize microarrays comprising large insert clones spaced at approximately one clone per Mb (12), but higher resolution arrays comprising overlapping clone sets for chromosomes or chromosome regions (13) and more recently for the whole genome (5) are being employed for more detailed and sensitive studies.
Array-CGH has been most widely applied for the analysis of gains and losses in tumours (14) but is increasingly becoming applied to the analysis of patients with constitutional rearrangements (15 -21) . We have specifically used array-CGH to identify small microdeletions and microduplications in patients with learning disability and dysmorphology who by conventional analysis had normal balanced karyotypes (15) . In a study of 50 such patients, we identified seven microdeletions and five microduplications and showed that in most cases the microdeletions were de novo and the microduplications inherited. Using the ability to flow sort aberrant chromosomes, we have been able to extend these analyses to patients with balanced translocations in a process we have called array painting, such that the composition and breakpoints of the rearrangement can be determined at high resolution providing the opportunity to identify candidate disease genes (17) . In array painting, the two derivative chromosomes in a balanced translocation are separated by flow sorting, differentially labelled and hybridized to a genomic clone array. Because only the DNA comprising each rearranged chromosome is analysed, the composition and breakpoints of the rearrangement can be directly determined by ratio changes from high to low (and vice versa) when the data are plotted according to chromosomal location. Surprisingly, in a study of only 10 patients with cytogenetically balanced translocations we found that six displayed unexpected karyotype complexity involving additional translocations, microdeletion, microduplication and inversion. Extending these studies to more focussed, higher resolution arrays allows us to more accurately define the specific breakpoints and the mechanisms involved in chromosome rearrangement. The development of arrays which are completely sequence-defined and repeat-free has allowed this resolution to be increased to 15 -20 kb (22) . More recently we have demonstrated that it is possible to use PCR products containing single coding exons of genes as a means for defining copy number changes at a resolution of 150 bp (P. Dhami and D. Vetrie, unpublished data, Fig. 2 ).
ANALYSIS OF CHROMOSOME STRUCTURE AND FUNCTION USING ChIP-ON-CHIP
While array-CGH has proved very useful for the analysis of gross chromosome structural aberrations, array technology is now being increasingly applied to the study of normal chromosome structure and function. The functional role of chromatin organization and modification and of associated proteins and complexes has now become well established (2 -4) and is involved in fundamental processes such as transcription, recombination, replication and DNA repair. DNA microarrays are being used to study these processes by combination with methods which allow fractionation of chromatin associated with function. Of these, one of the most powerful approaches is the use of chromatin imunoprecipitation (ChIP) where the chromatin associated with specific modifications or with proteins or protein complexes can be enriched, then quantified and mapped using microarrays. The use of chromatin immunoprecipitation with arrays has been termed ChIP-on-chip or ChIP-chip. This method has been well established for several years in organisms where the genome is less complex such as Saccharomyces cerevisiae and Drosophila. However, its application to the study of mammalian genomes is rapidly emerging with the availability of arrays which allow analysis of relevant subfractions of the genome (promoters, CpG islands, etc.) or entire tile paths of chromosomes or chromosomal regions, the latter allowing sequences of interest to be identified in an unbiased way.
The basic principles of ChIP-on-chip are shown in Figure 3 . The first important step in the process is the crosslinking of protein to the DNA with formaldehyde. The crosslinked DNA is sheared and then immunoprecipitated with a specific antibody to the protein of interest. This process not only precipitates the protein but also the DNA crosslinked to it. The crosslinking is then reversed and the associated DNA extracted. In many studies, the yield of extracted DNA is very low and either multiple extractions must be pooled or an amplification step must be employed before hybridization of the extracted DNA to the microarray. Typically, the enriched extracted DNA is compared on the array with unenriched DNA so that the pattern and extent of enrichment of the regions represented on the array can be determined. However, we have found that using advanced array technology, sensitivity and specificity can be improved to a level where pooling of samples or amplification of enriched DNA is no longer necessary (unpublished data, Fig. 4) . Thus, issues related to biases obtained due to the amplification process can be avoided, thus adding to the biological significance of the data obtained from such assays.
Modifications to the histone proteins which make up nucleosomes are tightly linked to the way in which the chromatin is packaged and in the regulation of gene expression. Modifications to the histone tails include acetylation, methylation, phosphorylation and ubiquitination. Microarrays have been used to map the distribution of such modifications using specific antibodies with chromatin immunoprecipitation. For example, Kondo et al. (23) used separate specific antibodies against acetylated and methylated histone H3 lysine 9 to immunoprecipitate acetylated and methylated histones from a cancer cell line, which were then hybridized to a human CpG island microarray. Using this approach, they were able to identify novel targets of gene silencing in cancer, since methylation at H3 lysine 9 is a central mechanism involved in gene repression and silencing (4) . We have also visualized histone modifications across tiled genomic regions providing clues of the chromatin state and transcriptional regulation of loci of interest (P. Dhami and D. Vetrie, unpublished data, Fig. 4 ). Such analyses provide new insights into the histone code hypothesis (24) and the relationship between DNA elements which control gene expression and chromatin structure.
Microarray analysis using ChIP-on-chip is particularly suited to the study of direct interaction of proteins and protein complexes with DNA. There are numerous examples of this in the study of the transcription-factor -DNA interactions in the human genome. Good early examples include detailed analysis of the E2F transcription-factor family which plays a critical role in cell cycle progression. Weinmann et al. (25) used chromatin immunoprecipitation with an antibody against E2F4 in combination with a human CpG island microarray to identify 68 unique targets, 25% of which recruit E2F by a mechanism other than through the known consensus binding sequence. Ren et al. (26) also investigated the co-ordinated regulation of genes by both E2F1 and E2F4 using ChIP in combination with an array containing the promoters of 1500 genes. Transcription-factor -DNA interactions have also been assayed using high resolution tile paths of human chromosomal regions (27) and entire chromosome tile paths (28 -30) , thus providing detailed information on the spatial organization of transcription-factor binding sites with respect to genes and other genome features.
The ChIP-on-chip approach has also been applied to the study of other functional chromosomal elements such as neocentromeres. Neocentromeres are regions of rearranged chromosomes which carry out the function of the normal centromere in providing mitotic stability in the aberrant chromosome. clone array of chromosome 13q31.3-13q33.1 to identify the precise location of three neocentromeres which had been previously localized by fluorescence in situ hybridization to 13q32. They showed that each of the neocentromeres was located at distinct locations and that there was no underlying sequence motif that could be found predisposing to neocentromere formation. Their data support the view that neocentromere formation is a sequence-independent epigenetic mechanism While high resolution arrays are most suited for the analysis of protein-DNA interactions due to the range over which binding occurs, current technology limits the scope of these arrays such that the whole genome cannot be scanned. Where this is required, it is currently necessary to use large insert clone arrays spanning the whole genome. We have used both 1 Mb resolution and chromosome tiling arrays to map the distribution of proteins associated with cellular senescence. We applied chromatin immunoprecipitated with an antibody against phosphorylated histone H2AX, a marker of DNA damage which associates with DNA damage and DNA checkpoint proteins, and showed that H2AX was specifically enriched at human chromosome telomeres (32) . We proposed that telomere-initiated senescence reflects a DNA damage checkpoint response that is activated by direct contribution from dysfunctional telomeres.
DNA METHYLATION
The methylation of DNA in most CpG dinucleotides is important in gene regulation in that methylation is an inhibitor of gene expression (33 -36) . In promoter regions associated with CpG islands, the methylated DNA is bound by proteins such as MeCP2 which in turn recruits histone deacetylase. The combination of methylated DNA and deacetylated histones generates a transcriptionally inactive chromatin state and gene silencing. The pattern of methylation and histone deacetylation changes during development and differentiation as different genes are switched on and off. DNA methylation is also intimately involved in genomic imprinting (37 -39) . Errors in DNA methylation or in the enzymes associated with methylation lead to disease such as Cranofacial and Rett Syndromes (40), Beckwith -Weidemann and Prader Willi/Angleman syndromes via errors in imprinting (41) . This also appears to be very important in cancer where the silencing of tumour suppressor genes is thought to be causative in many sporadic tumours (34) . As DNA methylation is so intimately involved in gene regulation, it is inevitable that the list of diseases where altered methylation patterns lead to altered gene expression and so to the disease state is likely to grow. DNA microarrays are now being employed to assess methylation patterns and several approaches have emerged. One approach uses methylation-sensitive restriction enzymes and DNA size selection (42) or specific PCR amplification to differentially amplify methylated and unmethylated loci (43, 44) . These products are then hybridized to an array where stronger hybridization indicates hypermethylation (43) . Using this approach, it has been possible to correlate hypermethylation with hormone status in breast tumours (45) and progression-free survival in ovarian cancer (46) . In an alternative approach, Gitan et al. (47) utilized bisulphite modification of DNA to convert unmethylated cytosines to uracil which after PCR is converted to thymine. Thus unmethylated sites can be distinguished from methylated sites by the conversion of cytosine to thymine after the bisulphite treatment. The conversion was detected by hybridization of the bisulphite-treated DNA to oligonucleotide arrays designed to be sensitive to the base change. Using this method, this group mapped methylated CpG sites within a human oestrogen receptor gene CpG island. Adorjan et al. (48) were able to use this type of approach to distinguish Figure 4 . ChIP-chip analysis using a genomic tiling path array. Fluorescently labelled unamplified ChIP DNA and genomic DNA were used in a competitive hybridization onto a PCR product-based array constituting a near complete tile path (400 bp resolution) of a 256 kb region of human chromosome at 1p32 containing the TAL1 locus. The plot shows the fold enrichment obtained for each PCR product (represented as joined-up red dots) in the ChIP DNA for histone H3 Lys4 trimethylation across the genomic region represented on the array (data courtesy of Pawandeep Dhami, unpublished data). H3 Lys4 trimethylation is associated with actively transcribed genes. The organization of genes across the region is shown at the bottom of the figure (green); the direction of transcription is denoted by the arrows under the blocks representing the genomic region encompassed by each gene.
between different types of leukaemia and between carcinomas and their corresponding normal tissues.
REPLICATION TIMING
It has been long known that DNA replication progresses in an ordered process where different parts of the genome replicate at different times through S phase. Regions of the genome being actively transcribed replicate early in S phase where as heterochromatin and regions of gene inactivity replicate late. We have developed a microarray-based method for assessing replication timing using DNA microarrays (49) , which extends studies in yeast (50) and Drosophila (51) to the human genome. The basis of the method is the separation, by flow cytometry, of nuclei in S phase from nuclei in G1 phase of the cell cycle from an asynchronously dividing cell population (Fig. 5) . The S phase fraction contains nuclei at all stages of replication including nuclei just entering S phase through to nuclei at the end of S phase. Loci which replicate early will have doubled their DNA content in most S phase nuclei, whereas loci which replicate late will remain at a single copy in the majority of nuclei. Thus the average DNA content of a locus in all of the cells in S phase will be directly related to the time through S phase at which the locus replicates. Thus the earliest locus to replicate will have twice the DNA content of the last locus to replicate. By hybridizing the differentially labelled S phase fraction against a reference where no replication has taken place (the G1 fraction), the relative ratio will theoretically vary by locus from 2: 1 (early replication) to 1: 1 (late replication). Using this approach we have measured the replication timing across the whole human genome using our array with a resolution of one large insert clone per 1 Mb as well as at higher resolution on an array of chromosome 22q containing overlapping clones (49) . Our results confirmed the correlation of early replication with high gene density, high GC content, high Alu repeat content and low SINE repeat content, and confirmed the correlation of the replication timing with the transcriptional state of the DNA by comparison with gene expression microarray analysis.
CONCLUSIONS
The application of microarrays to the study of chromosome structure and function is still in its infancy. The power of microarrays to quantify hybridization at high resolution over large areas of the genome is perfectly matched to methods that are able to separate the genomic DNA into functional fractions. As the technology develops, we can expect microarrays which are more sensitive, of higher resolution and that are more widely available and with this, increasing contributions to our understanding of chromosome structure and function.
